A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Research by Adrián Chapa‐Rodríguez focuses on the molecular mechanisms underlying non-alcoholic fatty liver disease (NAFLD). His work has investigated the role of SLAMF1, a protein expressed and secreted by hepatocytes, in mediating hepatocyte death within NAFLD models. Publications indicate that SLAMF1 expression in the liver and its plasma levels correlate with the severity of NAFLD in humans. Chapa‐Rodríguez's research also touches upon the transition of care for patients with eosinophilic gastrointestinal diseases, exploring associated challenges and opportunities. He has published 19 works with 872 citations and an h-index of 8.
Metrics
- h-index: 8
- Publications: 19
- Citations: 899
Selected Publications
-
Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities (2022)
-
SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis (2021)
Collaboration Network
Top Collaborators
Shripa Amatya
3 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Hrishikesh Samant
3 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Emma Burgos‐Ramos
3 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Diana Cruz‐Topete
3 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
J. Steven Alexander
Louisiana State University Health Sciences Center Shreveport (US)
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
Oscar Gómez
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Lilly Kamberov
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Hemangini A. Dhaibar
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Pranshu Khanna
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Kelly Nunez
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Paul Thevenot
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Ari Cohen
2 shared publications
- SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease
- OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human
Oscar Gomez Torres
University of Castilla-La Mancha (ES)
1 shared publication
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
Girish Hiremath
Monroe Carell Jr. Children's Hospital (US)
1 shared publication
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
David A. Katzka
WinnMed (US)
1 shared publication
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
Similar Researchers
Based on overlapping research topics
Stacie Jones
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Immune Response and Inflammation
Health Sciences Research and Education
Emily Tharp
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Immune Response and Inflammation
Health Sciences Research and Education
Børsheim Elisabet
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Liver Disease Diagnosis and Treatment
Health Sciences Research and Education
Emily Montoya
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Health Sciences Research and Education
Child and Adolescent Health
Saswat Das
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Health Sciences Research and Education
Child and Adolescent Health
T. Andrew Burrow
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Health Sciences Research and Education
Child and Adolescent Health